Skip to search.
 All Ordinaries Up 0.04%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.47 Up 0.04(1.64%) 01:34 - Nasdaq Real-Time Price
Add to Portfolio
Prev Close:2.43
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:9.42
Beta:1.72
Earnings Date:9 Mar - 13 Mar (Est.)
Day's Range:2.42 - 2.47
52wk Range:2.18 - 5.77
Volume:36,717
Avg Vol (3m):928,065
Market Cap:267.65M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTAUp 1.64%267.65M
INFIUp 0.87%797.89M
NVSUp 0.08%237.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Dec-14) :-0.21
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback